ProteoNic is a biotechnology company offering products and services for improving recombinant protein production levels for a range of eukaryotic production platforms. The company’s proprietary 2G UNic™ technology is used to enhance the translation of messenger RNA (mRNA) resulting in more protein per mRNA. This leads to significantly higher yields and greater manufacturing flexibility, with lower production costs.
ProteoNic’s main markets are the biopharmaceutical protein and industrial enzyme production sectors. The company’s activities focus on industry-relevant fungal, yeast, plant, insect and mammalian expression hosts, for which it has developed platform-specific products and services.
The 2G UNic™ technology toolbox products are provided under license agreement. In addition, ProteoNic offers contract services for expression vector construction and cell line or strain development in support of the implementation of 2G UNic™ technology.
The company is headquartered at the BioScience Park in Leiden, the Netherlands and has a Boston, USA office for Business Development in the North American market. ProteoNic is the winner of the 2010 Frost & Sullivan Technology Innovation Award.